Funding for this research was provided by:
Medizinischen Fakultät Heidelberg, Universität Heidelberg
Eva Luise und Horst Köhler Stiftung
Stiftung für Krebs und Scharlachforschung
Third Affiliated Hospital of Nantong University
Text and Data Mining valid from 2019-12-01
Received: 1 July 2019
Accepted: 8 November 2019
First Online: 11 December 2019
Ethics approval and consent to participate
: The ethics committee of the University of Heidelberg approved this study. Written informed consent was obtained from healthy donors and patients.
: Not applicable.
: WM has received consultancies, speaking fees and/or honoraria from Novartis and Roche (less than 10,000 each). RB has received speaking fees from Roche, Abbvie, BMS, Chugai, Novartis und Vifor (less than 10,000 each). H-ML has received consultancies, speaking fees and/or honoraria from Roche (less than 10,000 each). NB has received speaking fees / honoraria (less than 10,000 each) from Roche, Novartis, SOBI, Abbvie, UCB and Biomol.